September 6, 2016 Manufacturing and Production, Sales and Marketing Bayer, acqusition, monsanto

September 6, 2016 Manufacturing and Production, Research and Development Eisai, Germany, Halaven, IQWIG, german

September 6, 2016 Manufacturing and Production, Sales and Marketing Arcus, investment, taiho

September 6, 2016 Manufacturing and Production, Research and Development Horizon Discovery, crispr, fulcrum, fulcrum therapeutics, gene editing, horizon, rare diseases

September 6, 2016 Manufacturing and Production, Research and Development COPD, resmed

September 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Takeda, US government, Zika, world health organization

September 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing GlaxoSmithKline, Innoviva, Revlar Ellipta, chronic obstructive pulmonary disease

September 2, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile.com, top ten
September 1, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

September 1, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cloud Computing, ICON, clinical trials, ibm
September 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

September 1, 2016 Manufacturing and Production, Research and Development CAR-T, Novartis, cart, cell and gene therapies
August 31, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

August 31, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myer's Squibb, Bristol-Myers Squibb, CDF, Cancer Drugs Fund, Cloud Computing, Pharmafocus, Pharmafocus new issue, brexit, clinical trial transparaency, opdivo

August 30, 2016 Manufacturing and Production, Research and Development Teva, closure